Status:
UNKNOWN
The Effects of Respiratory-based Telerehabilitaion in Patients With MS
Lead Sponsor:
Dr. Anıl Tosun
Collaborating Sponsors:
Trakya University
Conditions:
Multiple Sclerosis
Telerehabilitation
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
During the pandemic, it is important for people who are isolated in their homes to stay inactive and exercise exercises in order to prevent their complaints from increasing due to inactivity. Individu...
Detailed Description
Multiple sclerosis is chronic and improves the quality of life of the person is a neurological disease that decreases. Multiple Sclerosis in mobility and functional activities cause restrictions in so...
Eligibility Criteria
Inclusion
- ambulatuar or non -ambulatuar
- All patients with diagnosed with Multiple Sclerosis. (Diagnosis of MS according to the revised McDonald Criteria 2017)
- An ability to understand and execute simple instructions.
- Aged 20-65 years old.
Exclusion
- patients with hearing, vision and cognitive problems.
- Pregnancy (self-reported)
- Orthopedic and other neurological disorders affecting upper limb movements (e.g., epileptic seizures)
- Contra-indication to physical activity (e.g., heart failure, severe osteoporosis) MS clinical relapse or treatment with corticosteroid therapy within 30 days prior to enrollment
- Started or stopped a disease-modifying therapy for MS within 30 days prior to enrollment
Key Trial Info
Start Date :
April 16 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 30 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04887051
Start Date
April 16 2021
End Date
August 30 2021
Last Update
May 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fenerbahce University
Istanbul, Turkey (Türkiye), 34758